New York Institute of Technology   Report issue

Academic/Hospital Phase 1
Founded: New York NY United States (1955)

Organization Overview

First Clinical Trial
2008
NCT01238926
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

New York Institute of Technology | NYIT col osteopathic medicine

Active Ingredients

Drugs in Phase 1 Trials (2)

nicotine (nicorette) (1 trial)

tyrosine (1 trial)

Drugs in Other Trials (4)

cyanocobalamin (berocca) (1 trial)

folic acid (1 trial)

pyridoxine (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypotension (Phase 1)

Parkinson Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 6